You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
30 September 2026 - Belgian biopharmaceutical company Oxurion NV (Euronext Brussels:OXUR) announced on Wednesday that it has entered into exclusive negotiations to acquire the business and operating assets of Eclevar, a French contract research organ...
30 September 2026 - Late-stage biopharmaceutical company DBV Technologies (Euronext:DBV) (Nasdaq:DBVT) announced on Wednesday that it has submitted a Biologics License Application to the US Food and Drug Administration (FDA) and requested Priority Re...
30 September 2026 - UTR Therapeutics Inc, a New York-based biotech company, announced on Tuesday that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to 3'UTRMYCN M1-14 (UTRxMYCN M1-14) for the treatment of soft tis...
29 September 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) announced on Tuesday that it has agreed to invest USD2bn in newly issued equity in biopharmaceutical oncology company Summit Therapeutics Inc (NASDAQ:SMMT) t...
29 September 2026 - Lakewood-Amedex Biotherapeutics Inc (NASDAQ:LABT), a clinical-stage biotechnology company focused on advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin cl...
29 September 2026 - BRC Therapeutics (BRC), a clinical-stage pharmaceutical company developing multimodal cannabinoid therapeutics for neurological and inflammatory conditions, announced on Monday its participation in the Regulatory Perspectives on H...
29 September 2026 - Chinese biotechnology company Ascletis Pharma Inc (HKEX:1672) on Monday reported positive results from a randomised, double-blind, placebo-controlled 28-day proof-of-concept clinical trial with ASC50 in mild-to-moderate plaque pso...